Loading…
West Pharmaceutical Services, Inc. is projected to rise to $369.87 by 2027, a +18% move from its current price of $312.71. WST is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $307.52 | $312.88 | $318.34 | +0.05% |
| May 30 | $305.49 | $313.05 | $320.80 | +0.11% |
| May 31 | $303.98 | $313.22 | $322.74 | +0.16% |
| Jun 1 | $302.74 | $313.39 | $324.42 | +0.22% |
| Jun 2 | $301.68 | $313.57 | $325.92 | +0.27% |
| Jun 3 | $300.73 | $313.74 | $327.31 | +0.33% |
| Jun 4 | $299.88 | $313.91 | $328.60 | +0.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $299.88 | $313.91 | $328.60 | +0.38% |
| Week 2 | $295.38 | $315.11 | $336.17 | +0.77% |
| Week 3 | $292.23 | $316.32 | $342.40 | +1.16% |
| Week 4 | $289.78 | $317.54 | $347.95 | +1.54% |
| Week 5 | $287.77 | $318.75 | $353.08 | +1.93% |
| Week 6 | $286.06 | $319.98 | $357.91 | +2.32% |
| Week 7 | $284.60 | $321.21 | $362.52 | +2.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc.
was founded in 1923 and is headquartered in Exton, Pennsylvania.
West Pharmaceutical Services, Inc. is a healthcare company focused on containment and delivery systems for injectable drugs and related medical products. The current price is $316.42, and the market cap stands at $22.35B, with a market ranking of 548.
The stock trades in a 30-day range of $280.59 to $356.83 and sits above key moving averages, with a SMA50 of $277.66 and a SMA200 of $264.62. This near-term setup supports a constructive view as price action remains above these benchmarks.
A major floor 26.1% below — a decisive break under it would weaken the trend.
The nearest floor, 14.8% below — buyers have tended to step in here.
The nearest ceiling, 4.2% above — a clean break opens room to run.
A major ceiling 15.5% above — clearing it would confirm fresh momentum.
Key WST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of WST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $313.39 | Sell | $312.88 | Sell |
| MA 10 | $308.08 | Buy | $310.90 | Buy |
| MA 20 | $308.97 | Buy | $305.61 | Buy |
| MA 50 | $280.72 | Buy | $288.46 | Buy |
| MA 100 | $265.37 | Buy | $275.59 | Buy |
| MA 200 | $265.36 | Buy | $267.93 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.59 | Neutral |
| Stoch RSI (14) | 25.33 | Neutral |
| CCI (20) | 32.58 | Neutral |
| Williams %R (14) | -51.34 | Info |
| MACD (12,26,9) | -1.29 | Sell |
| ROC (12) | -4.05 | Sell |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 48.66 | Neutral |
| TRIX (15) | 0.51 | Buy |
| Awesome (5,34) | 17.22 | Buy |
| Ultimate (7,14,28) | 67.55 | Neutral |
| Momentum (10) | 0.64 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 318.55 | Sell |
| ADX (14) | 27.51 | Buy |
| ATR (14) | 4.25 | Info |
Sentiment is BULLISH and the RSI14 is 60. The stock is trading above both the SMA50 ($277.66) and the SMA200 ($264.62). Support is at $259.96 and resistance at $325.92. The 30-day range runs from $280.59 to $356.83, reflecting orderly volatility and room for directional movement.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $230.95 | $312.71 | $396.84 | 0% | Neutral | |
| $302.16 | $369.87 | $473.91 | +18% | Neutral | |
| $341.55 | $425.72 | $559.72 | +36% | Bullish | |
| $409.81 | $518.54 | $695.95 | +66% | Bullish | |
| $460.16 | $590.01 | $805.88 | +89% | Bullish | |
| $499.84 | $648.62 | $899.75 | +107% | Bullish | |
| $538.28 | $706.32 | $993.56 | +126% | Bullish | |
| $544.48 | $721.94 | $1,028.54 | +131% | Bullish | |
| $604.23 | $809.07 | $1,166.32 | +159% | Bullish | |
| $720.07 | $973.26 | $1,418.51 | +211% | Bullish | |
| $995.99 | $1,403.83 | $2,143.52 | +349% | Bullish | |
| $1,825.49 | $2,759.07 | $4,514.59 | +782% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $230.95 | $312.71 | $365.87 | +0.00% |
| June 2026 | $273.21 | $318.71 | $379.01 | +1.92% |
| July 2026 | $280.16 | $328.71 | $394.59 | +3.14% |
| August 2026 | $277.48 | $327.02 | $395.43 | -0.51% |
| September 2026 | $271.63 | $321.32 | $390.83 | -1.74% |
| October 2026 | $273.81 | $325.00 | $397.45 | +1.15% |
| November 2026 | $275.18 | $327.61 | $402.53 | +0.80% |
| December 2026 | $269.32 | $321.55 | $396.84 | -1.85% |
Click any year to see its month-by-month WST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
West Pharmaceutical Services, Inc.'s 2026 outlook centres on $312.71, within a $230.95 to $396.84 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, WST could reach as high as $473.91, with a base case around $369.87 and support toward $302.16 — roughly +18% from $312.71. Price action looks broadly range-bound.
Expect WST to range from $341.55 to $559.72 through 2028. The $425.72 average target implies a +36% move from current prices. That is up +15% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The WST price prediction for 2029 points to an average of $518.54 (low $409.81, high $695.95) — a potential gain of +66% on today's $312.71. Momentum favours further upside here.
In 2030, WST is projected to trade between $460.16 and $805.88, averaging $590.01 — a potential gain of +89% from today's $312.71. That is up +14% on the projected 2029 average. Buyers look set to stay in control over this stretch.
West Pharmaceutical Services, Inc.'s 2031 outlook centres on $648.62, within a $499.84 to $899.75 range. That is up +10% on the projected 2030 average. That marks a +107% change versus current levels. Momentum favours further upside here.
By 2032, WST could reach as high as $993.56, with a base case around $706.32 and support toward $538.28 — roughly +126% from $312.71. Buyers look set to stay in control over this stretch.
Expect WST to range from $544.48 to $1,028.54 through 2033. The $721.94 average target implies a +131% move from current prices. That is up +2% on the projected 2032 average. Momentum favours further upside here.
The WST price prediction for 2034 points to an average of $809.07 (low $604.23, high $1,166.32) — a potential gain of +159% on today's $312.71. Buyers look set to stay in control over this stretch.
In 2035, WST is projected to trade between $720.07 and $1,418.51, averaging $973.26 — a potential gain of +211% from today's $312.71. That is up +20% on the projected 2034 average. Momentum favours further upside here.
West Pharmaceutical Services, Inc.'s 2040 outlook centres on $1,403.83, within a $995.99 to $2,143.52 range. That is up +44% on the projected 2035 average. That marks a +349% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, WST could reach as high as $4,514.59, with a base case around $2,759.07 and support toward $1,825.49 — roughly +782% from $312.71. Momentum favours further upside here.
Investing $1,000 in WST today (≈ 3.197851 WST) could be worth
$8,823.11
+$7,823.11 (+782%) by 2050 · US Dollar
Based on the average projected WST price of $2,759.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in WSTwould be worth at today's price.
$1,000 invested in WST on May 27, 2025 (≈ 4.738887 WST) would be worth
$1,481.9
+$481.9 (+48.2%) today · 1.48× · US Dollar
Based on a WST entry price of $211.02 vs. today's $312.71.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $305.5 | $1,023.6 | +2.4% |
| 1 month ago | $302.2 | $1,034.78 | +3.5% |
| 3 months ago | $249.02 | $1,255.76 | +25.6% |
| 6 months ago | $277.25 | $1,127.9 | +12.8% |
| 1 year ago | $211.02 | $1,481.9 | +48.2% |
| All time (5.0y) ago | $340.16 | $919.3 | -8.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our WST forecast.
Our base-case forecast reaches $630.00 around 2031.
Implied market cap at $630.00: $44.51B
The multi-year forecast shows a rising price path with a mix of neutral and bullish signals across the years. In 2026 the avg price is $316.42 with a min of $230.95 and a max of $402.93 (sentiment NEUTRAL, ROI 0). From 2027 onward, the forecast turns BULLISH, with 2027 avg $382.44 (ROI 20.9), 2028 avg $441.99 (ROI 39.7), 2029 avg $539.71 (ROI 70.6), and 2030 avg $621.69 (ROI 96.5).
The 2030 max is $849.35 and the 2040 max reaches $2,325.51 with a 2040 avg of $1,522.83 (ROI 381.3). By 2050, the forecasted avg price is $3,015.98 (ROI 853.2) with a max of $4,935.39. The 2050 max and the sustained bullish sentiment imply substantial upside potential, albeit these are estimates, not guarantees and carry inherent uncertainty.
Tap a question to reveal the answer.
2030 min $484.78, avg $621.69, max $849.35; ROI 96.5%; sentiment BULLISH.
Forecasts show a bullish path from 2027 onward, with rising avg prices to $621.69 by 2030 and to $3,015.98 by 2050, and ROI of 96.5% by 2030 and 853.2% by 2050.
Yes—the 2050 forecast max is $4,935.39.
Yes. The 2029 min is $426.46, the avg is $539.71, and the max is $724.56, so $500 falls within the forecast range for 2029.
Current price is $316.42 and market cap is $22.35B.
West Pharmaceutical Services, Inc. Community Discussion
0Share your West Pharmaceutical Services, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.